Results 261 to 270 of about 38,272 (314)

Implementation of a Potential Industrial Green, Economical, and Safe Strategy to Enhance Commercial Viability of Liquid Self-Nanoemulsifying Drug Delivery System. [PDF]

Pharmaceutics
Sherif AY, Altamimi MA, Elzayat EM.
europepmc   +1 more source

Empagliflozin and Dapagliflozin Outcomes in Heart Failure.

JAMA Netw Open
Bu S, Jung MH, Lee D, Hwang YM, Cho JS, Yi JE, Kim H, Kim S, Chung D, Shin DH, Aung N, Ahn HS.   +11 more
europepmc   +1 more source

Study protocol of a multicenter, randomized, non-inferiority, open-label study investigating the efficacy of a fixed-dose combination regimen of dapagliflozin/metformin versus co-administered dual therapy based on glycemic control, satisfaction and adherence in patients with newly diagnosed type 2 diabetes mellitus. [PDF]

Front Endocrinol (Lausanne)
Wang J, Wei Y, Shi P, Chen J, Xu L, Kong Y, Ye J, Wang X, Xu J, Wang G.   +9 more
europepmc   +1 more source

Knowledge domain and emerging trends on the SGLT2 inhibitor dapagliflozin for heart failure: a bibliometric analysis from 2012 to 2024. [PDF]

J Cardiothorac Surg
Xiao M, Sui Y, Fu D, Gong S, Xiong N, Wu Y, Xiong W.   +6 more
europepmc   +1 more source

Comparative Long-Term Cardiovascular Outcomes of Empagliflozin and Dapagliflozin in Heart Failure Patients After Coronary Revascularization: A Retrospective Cohort Study. [PDF]

J Clin Med
Ozgol I, Yildiz C, Yigit Gencer E, Karabulut D, Caglar FNT, Bicakhan B, Yilmaz M, Karabulut U, Gokkurt Y, Yigit Z.   +9 more
europepmc   +1 more source

Effects of Dapagliflozin in Combination with Hydrochlorothiazide on Cardiac Remodeling in Rats with Heart Failure After Myocardial Infarction

Jinghong Luo, Ling Li, Zeng Qingchun
openalex   +2 more sources

SGLT2 Inhibitors and Complicated Urinary Tract Infections: A Rare Case of Emphysematous Pyelonephritis and Subsequent Recurrence Associated With Dapagliflozin Use. [PDF]

Clin Case Rep
Kaur H, Chauhan S, Yadav M.
europepmc   +1 more source

Patient-Centered Outcomes in Heart Failure Pharmacotherapy: A Meta-Analysis of Randomized Controlled Trials. [PDF]

JACC Adv
Kido K, Hashiguchi M, Guglin M.
europepmc   +1 more source

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Sankarsan Das, Asit Kumar Mallick, Narayana Behera   +2 more
openalex   +1 more source